1,317
Views
11
CrossRef citations to date
0
Altmetric
Review Article

Diagnostic accuracy of procalcitonin for bacterial pneumonia in children – a systematic review and meta-analysis

, , , , , & show all
Pages 683-697 | Received 13 May 2020, Accepted 23 Jun 2020, Published online: 02 Jul 2020

References

  • Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(2):ii1–ii23.
  • Morris SS, Black RE, Tomaskovic L. Predicting the distribution of under-five deaths by cause in countries without adequate vital registration systems. Int J Epidemiol. 2003;32(6):1041–1051.
  • Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408–416.
  • Shah SN, Bachur RG, Simel DL, et al. Does this child have pneumonia?: The rational clinical examination systematic review. JAMA. 2017;318(5):462–471.
  • Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25–e76.
  • Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics. 2003;112(4):951–957.
  • Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845.
  • Tsou PY, Chen KP, Wang YH, et al. Diagnostic accuracy of lung ultrasound performed by novice versus advanced sonographers for pneumonia in children: a systematic review and meta-analysis. Acad Emerg Med. 2019;26(9):1074–1088.
  • Flood RG, Badik J, Aronoff SC. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children. Pediatr Infect Dis J. 2008;27(2):95–99.
  • Chen YS, Liu PY, Huang YF, et al. Comparison of diagnostic tools with multiplex polymerase chain reaction for pediatric lower respiratory tract infection: a single center study. J Microbiol Immunol Infect. 2013;46(6):413–418.
  • Murdoch DR, Anderson TP, Beynon KA, et al. Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol. 2003;41(1):63–66.
  • Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79(6):1605–1608.
  • Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10:CD007498.
  • McCluskey SM, Schuetz P, Abers MS, Bearnot B, et al. Serial procalcitonin as a predictor of bacteremia and need for intensive care unit care in adults with pneumonia, including those with highest severity: a prospective cohort study. Open Forum Infect Dis. 2017;4(1):ofw238.
  • Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57(9):1308–1318.
  • Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302(10):1059–1066.
  • Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600–607.
  • Tonkin-Crine SK, Tan PS, van Hecke O, et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev. 2017;9:CD012252.
  • Moulin F, Raymond J, Lorrot M, Marc E, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child. 2001;84(4):332–336.
  • Korppi M, Don M, Valent F, et al. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Paediatr. 2008;97(7):943–947.
  • Stockmann C, Ampofo K, Killpack J, et al. Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia. J Pediatric Infect Dis Soc. 2018;7(1):46–53.
  • McInnes MDF, Moher D, Thombs BD, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: The PRISMA-DTA statement. JAMA. 2018;319(4):388–396.
  • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
  • Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • van Enst WA, Ochodo E, Scholten RJ, et al. Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study. BMC Med Res Methodol. 2014;14:70
  • Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463.
  • Fonseca TS, Vasconcellos AG, Gendrel D, et al. Recovery from childhood community-acquired pneumonia in a developing country: prognostic value of serum procalcitonin. Clin Chim Acta. 2019;489:212–218.
  • İşgüder R, Ceylan G, Ağın H, et al. New parameters for childhood ventilator associated pneumonia diagnosis. Pediatr Pulmonol. 2017;52(1):119–128.
  • Erdman LK, D'Acremont V, Hayford K, et al. Biomarkers of host response predict primary end-point radiological pneumonia in Tanzanian children with clinical pneumonia: a prospective cohort study. PLoS One. 2015;10(9):e0137592.
  • Galetto-Lacour A, Alcoba G, Posfay-Barbe KM, et al. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children. Pediatr Infect Dis J. 2013;32(11):1175–1179.
  • Lee JY, Hwang SJ, Shim JW, et al. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia. Korean J Lab Med. 2010;30(4):406–413.
  • Nascimento-Carvalho CM, Cardoso MR, Barral A, et al. Procalcitonin is useful in identifying bacteraemia among children with pneumonia. Scand J Infect Dis. 2010;42(9):644–649.
  • Don M, Valent F, Korppi M, et al. Differentiation of bacterial and viral community-acquired pneumonia in children. Pediatr Int. 2009;51(1):91–96.
  • Don M, Valent F, Korppi M, et al. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood. Scand J Infect Dis. 2007;39(2):129–137.
  • Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113(4):701–707.
  • Korppi M, Remes S, Heiskanen-Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings. Pediatr Pulmonol. 2003;35(1):56–61.
  • Dago-Oc F, Requiron-Sy M, Astrologio G, et al. P93 Utilization of procalcitonin as a diagnostic biomarker of paediatric ventilator-associated pneumonia in patients with congenital heart disease following cardiac surgery. Thorax. 2018;73(4):A153–A154.
  • Alcoba G, Keitel K, Maspoli V, et al. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR. Eur J Pediatr. 2017;176(6):815–824.
  • Hoshina T, Nanishi E, Kanno S, et al. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis. J Infect Chemother. 2014;20(10):616–620.
  • Laham JL, Breheny PJ, Gardner BM, et al. Procalcitonin to predict bacterial coinfection in infants with acute bronchiolitis: a preliminary analysis. Pediatr Emerg Care. 2014;30(1):11–15.
  • Schutzle H, Forster J, Superti-Furga A, et al. Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis. Eur J Pediatr. 2009;168(9):1117–1124.
  • Desmarest M, Aupiais C, Le Gal J, et al. Dosage de la procalcitonine et bronchiolites vues dans un service d’accueil des urgences pédiatriques. Archives de Pédiatrie. 2017;24(11):1060–1066.
  • Khan DA, Rahman A, Khan FA. Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children? J Clin Lab Anal. 2010;24(1):1–5.
  • Diez-Padrisa N, Bassat Q, Morais L, et al. Procalcitonin and C-reactive protein as predictors of blood culture positivity among hospitalised children with severe pneumonia in Mozambique. Trop Med Int Health. 2012;17(9):1100–1107.
  • Korppi M. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination? Pediatr Int. 2004;46(5):545–550.
  • Garcia-Zarza Martinez E, Ramos Amador JT, Rubio Gribble B, et al. [Utility of serum procalcitonin as a diagnostic guide in children with community-acquired pneumonia]. An Pediatr (Barc). 2004;60(3):279–281.
  • Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J. 2000;19(7):598–602.
  • Prat C, Dominguez J, Rodrigo C, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J. 2003;22(11):963–968.
  • Kamat IS, Ramachandran V, Eswaran H, et al. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2020;70(3):538–542.
  • Self WH, Balk RA, Grijalva CG, et al. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clin Infect Dis. 2017;65(2):183–190.
  • Branche AR, Walsh EE, Vargas R, et al. Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial. J Infect Dis. 2015;212(11):1692–1700.
  • Lee CC, Chang JC, Mao XW, Hsu WT, et al. Combining procalcitonin and rapid multiplex respiratory virus testing for antibiotic stewardship in older adult patients with severe acute respiratory infection. J Am Med Dir Assoc. 2020;21(1):62–67.
  • Neuman MI, Hall M, Lipsett SC, et al. Utility of blood culture among children hospitalized with community-acquired pneumonia. Pediatrics. 2017;140(3):e20171013.
  • Yu CW, Juan LI, Wu MH, et al. Systematic review and meta-analysis of the diagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count for suspected acute appendicitis. Br J Surg. 2013;100(3):322–329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.